Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 9:11 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 481–504 of 2,449 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Implant Clear all

Conditions: Cardiovascular Disease
Interventions: FEIBA, Normal Saline; Drug
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Wisdom Teeth, Wisdom Teeth Extraction or Jaw Implant
Interventions: NEUROCUPLE™ Patch, Sham Patch; Device
Lead sponsor: nCap Medical; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Acute Coronary Syndrome, Myocardial Infarction, Coronary Artery Disease, Percutaneous Coronary Intervention
Interventions: CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin, Plavix (clopidogrel 75 mg) and aspirin; Drug
Lead sponsor: Cogentus Pharmaceuticals; Industry
Eligibility: 21 Years and older
Enrollment: 5,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 247
States / cities: Alexander City, Alabama • Birmingham, Alabama • Geneva, Alabama + 205 more

Conditions: Breast Implants
Interventions: Saline-filled breast implant [IDEAL IMPLANT (R)]; Device
Lead sponsor: Ideal Implant Incorporated; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2021
U.S. locations: 24
States / cities: Beverly Hills, California • Folsom, California • Huntington Beach, California + 21 more

Conditions: Appendicitis, Cholelithiasis, Malignant Hypertension
Interventions: single incision laparoscopic surgery; Procedure
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years to 75 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: San Diego, California

Conditions: Pain
Interventions: 2% lidocaine gel, Placebo gel; Drug
Lead sponsor: Women and Infants Hospital of Rhode Island; Other
Eligibility: 18 Years to 49 Years · Female only
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 2
States / cities: Providence, Rhode Island

Conditions: CNS Tumor
Interventions: Not listed
Lead sponsor: Arbor Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 272 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2025
U.S. locations: 31
States / cities: Huntsville, Alabama • Phoenix, Arizona • Scottdale, Arizona + 28 more

Conditions: Prostate Cancer
Interventions: 125-Iodine, 103-palladium; Radiation
Lead sponsor: Radiation Therapy Oncology Group; Network
Eligibility: 18 Years to 120 Years · Male only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2022
U.S. locations: 13
States / cities: Phoenix, Arizona • Fresno, California • Aurora, Colorado + 10 more

Conditions: Heart Failure, Nonischemic Cardiomyopathy, Ischemic Cardiomyopathy, Ventricular Arrhythmia, Complications; Device, Cardiac
Interventions: Not listed
Lead sponsor: American College of Cardiology; Other
Eligibility: Not listed
Enrollment: 1,750 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2030
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Advanced Breast Cancer, Early Breast Cancer
Interventions: ZOLADEX; Drug
Lead sponsor: TerSera Therapeutics LLC; Industry
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 176 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 28
States / cities: Hot Springs, Arkansas • Washington D.C., District of Columbia • Miami, Florida + 25 more

Conditions: Cataract
Interventions: Levofloxacin Ocular Implant; Drug
Lead sponsor: PolyActiva Pty Ltd; Industry
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 2
States / cities: St Louis, Missouri • Ladson, South Carolina

Conditions: Edentulism
Interventions: Ankylos Implants, Biomet 3i Prevail Implants; Device
Lead sponsor: Dentsply International; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Heart Failure
Interventions: Implantable Hemodynamic Monitor (Chronicle® IHM), and IHM in combination with single chamber ICD (Chronicle ICD); Device
Lead sponsor: Medtronic Cardiac Rhythm and Heart Failure; Industry
Eligibility: 18 Years and older
Enrollment: 442 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 52
States / cities: Birmingham, Alabama • La Jolla, California • Loma Linda, California + 43 more

Conditions: Indication for Care or Intervention Related to Labor or Delivery With Baby Delivered
Interventions: Not listed
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: Female only
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Device:MRI
Interventions: Device: MRI; Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 9 Years to 100 Years
Enrollment: 4,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Heart Failure
Interventions: Automated HF/EP Referral, Placebo (Registry Arm); Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 77 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Epilepsy
Interventions: electrical stimulation; Other
Lead sponsor: Barbara Jobst; Other
Eligibility: 18 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2025
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Pain
Interventions: 2% lidocaine gel, Water based lubricant; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Mammaplasty, Mastectomy, Lumpectomy
Interventions: Brava Autologous Fat Transfer System; Device
Lead sponsor: Brava; Industry
Eligibility: 18 Years to 80 Years · Female only
Enrollment: 589 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2015
U.S. locations: 2
States / cities: Miami, Florida

Conditions: Clinical Efficacy
Interventions: Intrasocket graft, Intrasocket plus facial overlay graft; Procedure
Lead sponsor: University of Louisville; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: IUD Insertion Pain, IUD Insertion
Interventions: Benzocaine 20%, Lidocaine 2%, Sham injection, Saline 0.9%; Drug · Other
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 18 Years and older · Female only
Enrollment: 1 participant
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Popliteal Nerve Block, Foot Surgery, Ankle Surgery, Popliteal Bifurcation
Interventions: Catheter Placed At Bifurcation, Catheter Placed 5cm Above Bifurcation; Procedure
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 1
States / cities: San Diego, California

Conditions: Cochlear Implant
Interventions: place-based mapping, default mapping; Other
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 80 Years
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Peri-implant Alveolar Bone Thickness
Interventions: DFDBA + Bio-Gide Membrane, Non-FDBA; Biological · Other
Lead sponsor: Creighton University; Other
Eligibility: 21 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Omaha, Nebraska

Search by objective public record fields.

FEIBA and Use of Blood Products in Cardiac Surgery

NeuroCuple to Mitigate Post-Wisdom Teeth Extraction Opioid Risks

Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)

Core Study of the Safety and Effectiveness of IDEAL IMPLANT(R) Saline-filled Breast Implants

Single Incision Laparoscopy

A Trial of 2% Lidocaine Gel for Intrauterine Device (IUD) Insertion

Vigilant ObservatIon of GlIadeL WAfer ImplaNT Registry

Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy

Implantable Cardioverter Defibrillator (ICD Registry)

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer

Levofloxacin Ocular Implant for Ocular Surgery

Success Rate of Immediately Loaded Implants With Platform Switched Design Placed in Anterior Part of Mandible and Restored With Fixed Prostheses

Reducing Decompensation Events Utilizing Intracardiac Pressures in Patients With Chronic Heart Failure (HF) (REDUCEhf)

Incidence of Difficult Airway and Difficult Neuraxial Placement in Obstetric Patients

Magnetic Resonance Imaging (MRI) in Patients With Pacemakers and Implanted Cardioverter Defibrillators

Automated MEdical Record Driven Implantable CArdioverter-defibrillator Heart Failure Trial (AMERICA-HF)

Navigation and Free Recall in Chronically Implanted Humans

Cervical Lidocaine for Intrauterine Device Insertion Pain

Breast Reconstruction and Augmentation With Brava Enhanced Autologous Fat Micro Grafting

Ridge Preservation Comparing an Intrasocket Graft Alone to an Intrasocket Graft Plus a Facial Overlay Graft

Intrauterine Device Insertion Pain Management

Continuous Popliteal Nerve Blocks: Effect of Perineural Catheter Tip Location Relative to the Sciatic Nerve Bifurcation on Postoperative Analgesia

Place-based Mapping in EAS Listeners

Effects of Bone Graft Placement at Implant Installation on Buccal Plate Stability